You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 124 No. 8, August 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Apolipoprotein E Phenotypes, Lipoprotein Composition, and Xanthelasmas

Juan A. Gómez, MD; María J. Gónzalez, MD; José M. de Moragas, MD; José Serrat, PhD; Francisco Gónzalez-Sastre, MD; Montserrat Pérez, MD

Arch Dermatol. 1988;124(8):1230-1234.


Abstract

• The different types of serum lipoproteins, including apolipoprotein E phenotypes, were measured in 50 patients with xanthelasma. Half of them were found to be hyperlipemic. The normolipemic and hyperlipemic groups with xanthelasma were compared with two control groups (one a group of normolipemic patients and another a group of hyperlipemic patients without xanthelasma) selected as homogeneously as possible with regard to age, sex, degree of obesity, and hyperlipemic phenotype. The only significant differences found among the groups, regardless of the presence of hyperlipemia, were the increased levels of total and high-density lipoprotein phospholipids, and lower levels of apolipoprotein B, found in the group with xanthelasmas. The distribution of apolipoprotein E phenotypes was the same in both groups, with slight differences between the normolipemic and hyperlipemic groups. Patients with xanthelasmas showed slight deviations in the metabolism of lipoproteins that require further clarification.

(Arch Dermatol 1988;124:1230-1234)



Author Affiliations

From the Departments of Biochemistry (Drs Gómez, Serrat, and Gónzalez-Sastre) and Dermatology (Drs Gónzalez, de Moragas, and Pérez), Hospital San Pablo, Autonomous University of Barcelona (Spain).


Footnotes

Accepted for publication Feb 24, 1988.

Reprint requests to Department of Biochemistry, Hospital San Pablo, Avda S Anto Ma Claret 167, 08025 Barcelona, Spain (Dr Gómez).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Dyslipoproteinemia in Patients With Xanthelasma
Pinto et al.
Arch Dermatol 1989;125:1281-1282.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.